[1]李盛华,刘一飞,谢兴文,等.基于“脾为之卫”理论探讨骨质疏松症与肠道免疫相关性[J].中国中医药信息杂志,2019,26(10):7-10.[doi:10.3969/j.issn.1005-5304.2019.10.003]
 LI Shenghua,LIU Yifei,XIE Xingwen,et al.Discussion on Correlation Between Osteoporosis and Intestinal Immunity Based on the Theory of “The Spleen for Defend”[J].zhongguo zhongyiyao xinxi zazhi,2019,26(10):7-10.[doi:10.3969/j.issn.1005-5304.2019.10.003]
点击复制

基于“脾为之卫”理论探讨骨质疏松症与肠道免疫相关性

参考文献/References:

[1] 邵铁娟,李海昌,谢志军,等.基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J].中华中医药杂志,2014,29(12):3762-3765.
[2] 张新乐,巫旭娜,陈文双,等.人参花蕾对D-半乳糖大鼠骨代谢的影响[J].中国药理学通报,2017,33(8):1152-1158.
[3] 王芳,高英,李卫民,等.黄芪散对糖尿病大鼠股骨和胫骨的作用研究[J].中国骨质疏松杂志,2016,22(3):278-282.
[4] 贾朝娟,鞠大宏,刘梅洁,等.山药对卵巢切除大鼠骨质疏松症的治疗作用及其机理探讨[J].中国中医基础医学杂志,2009,15(4):268-271.
[5] 王珍,刘友章,王秀丽.“脾为之卫”理论浅探[J].新中医,2011,43(3):5-7.
[6] 刘杰民,蔺晓源,王敏,等.基于肠道黏膜免疫的“脾为之卫”理论探讨[J].中国中医基础医学杂志,2013,19(4):460.
[7] AIDY S E, BARRLEN P V, DERRIEN M, et al. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice[J]. Mucosal Immunology,2014,5(5):567-579.
[8] NAGASHIMA K, SAWA S, NITTA T, et al. Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota[J]. Nature Immunology,2017,18(6):675-682.
[9] MIN Y W, RHEE P L. The role of microbiota on the gut immunology[J]. Clinical Therapeutics,2015,37(5):968-975.
[10] 李明美,周艳,李亚齐,等.肠道菌群对肠粘膜免疫系统影响的研究进展[J].生命的化学,2017,37(6):895-900.
[11] 巩静,陈广,王定坤,等.从脾胃论治糖尿病与肠道菌群的关系[J].中国中西医结合杂志,2016,36(4):484-487.
[12] 唐华羽,李玉芝,李长德,等.四君子汤总多糖对小鼠肠道菌群及免疫功能的影响[J].陕西中医,2016,37(12):1688-1691.
[13] 邓昶,周明旺,付志斌,等.骨质疏松症的中医病因病机及其治疗进展[J].中国骨质疏松杂志,2017,23(8):1105-1111.
[14] 周龙云,郭杨,黄桂成,等.骨质疏松症“病本在脾,以阴阳两虚为要”之见探讨[J].中国骨质疏松杂志,2016,22(4):487-491.
[15] GUSS J D, HORSFIELD M W, FONTENELE F F, et al. Alterations to the gut microbiome impair bone strength and tissue material properties[J]. Journal of Bone & Mineral Research,2017,32(6):1343-1353.
[16] YAN J, HERZOG J W, TSANG K, et al. Gut microbiota induce IGF-1 and promote bone formation and growth[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016,113(47):E7554-E7563.
[17] DAO M C, EVERARD A, ARON-WISNEWSKY J, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity:relationship with gut microbiome richness and ecology[J]. Gut,2016,65(3):426-436.
[18] SJ?GREN K, ENGDAHL C, HENNING P, et al. The gut microbiota regulates bone mass in mice[J]. Journal of Bone and Mineral Research,2012,27(6):1357-1367.
[19] XIAO Y, LONG Y, CHENG C H, et al. Intestinal microbiota a potential target for the treatment of postmenopausal osteoporosis[J]. Bone Research,2017,5(3):177-194.
[20] 宋敏,周灵通,刘小钰,等.消化系统疾病并发骨质疏松症与肠道菌群的关系探讨[J].中国骨质疏松杂志,2018,24(1):130-134.
[21] ALI T, LAM D, BRONZE M S, et al. Osteoporosis in inflammatory bowel disease[J]. American Journal of Medicine,2009,122(7):599-604.
[22] MARATOVA K, HRADSKY O, MATYSKOVA J, et al. Musculoskeletal system in children and adolescents with inflammatory bowel disease:normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fractures[J]. European Journal of Pediatrics,2017,176(10):1355-1363.
[23] 刘杰民,黄盛文,董菲洛,等.健脾益肠散合固本保元腹袋治疗溃疡性结肠炎的疗效及机制[J].吉林中医药,2011,31(1):42-43.
[24] 冯歆,葛继荣.中医从脾论治原发性骨质疏松症的研究进展[J].中国骨质疏松杂志,2014,20(8):968-972.

备注/Memo

基金项目:国家中医临床研究基地业务建设科研专项(JDZX2015080);甘肃陇中正骨学术流派传承工作室建设项目(LP0128061);兰州市科技计划(2016-3-102);甘肃省科技计划(18JR2TA016)

更新日期/Last Update:

2019-09-18